Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9123)
All Articles published online
|
Publishing Process of This Article
|
Dec 24, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Transplantation
ISSN
2220-3230
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Presland RB. Biology of chronic graft-vs-host disease: Immune mechanisms and progress in biomarker discovery. World J Transplant 2016; 6(4): 608-619 [PMID: 28058210 DOI: 10.5500/wjt.v6.i4.608] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3230/full/v6/i4/608.htm |
| Number | Citing Articles |
| 1 |
Zhi-zhi Qin, Jun Ruan, Meng-ran Lee, Kang Sun, Ping Chen, Yan Chen, Mei Hong, Ling-hui Xia, Jun Fang, Hao Tang. Mangiferin Promotes Bregs Level, Activates Nrf2 Antioxidant Signaling, and Inhibits Proinflammatory Cytokine Expression in Murine Splenic Mononuclear Cells In Vitro. Current Medical Science 2021; 41(3): 454 doi: 10.1007/s11596-021-2371-9
|
| 2 |
Mauricio Sarmiento Maldonado, Pablo Ramírez Villanueva, Pablo Bertín Cortes-Monroy, Veronica Jara Arias, Katherine Soto Donoso, Pablo Uribe Gonzalez, Mauricio Ocqueteau Tachini, Jose Antonio Perez-Simón. Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis. Experimental Hematology & Oncology 2017; 6(1) doi: 10.1186/s40164-017-0092-3
|
| 3 |
Daniela Roca, Jessica Mun, Bayasgalan Surenkhuu, Murugesan Vanathi, Sandeep Jain. Dry Eye Disease. 2023; : 107 doi: 10.1016/B978-0-323-82753-9.00015-1
|
| 4 |
Philipp Eberwein, Sonja Krösser, Philipp Steven. Semifluorinated Alkane Eye Drops in Chronic Ocular Graft-versus-Host Disease: A Prospective, Multicenter, Noninterventional Study. Ophthalmic Research 2020; 63(1): 50 doi: 10.1159/000499158
|
| 5 |
|
| 6 |
Asma El‐Howati, Martin H. Thornhill, Helen E. Colley, Craig Murdoch. Immune mechanisms in oral lichen planus. Oral Diseases 2023; 29(4): 1400 doi: 10.1111/odi.14142
|
| 7 |
Nathaniel Edward Bennett Saidu, Chiara Bonini, Anne Dickinson, Magdalena Grce, Marit Inngjerdingen, Ulrike Koehl, Antoine Toubert, Robert Zeiser, Sara Galimberti. New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.578314
|
| 8 |
Sridevi Nair, Murugesan Vanathi, Ritika Mukhija, Radhika Tandon, Sandeep Jain, Yoko Ogawa. Update on ocular graft-versus-host disease. Indian Journal of Ophthalmology 2021; 69(5): 1038 doi: 10.4103/ijo.IJO_2016_20
|
| 9 |
Deepika Raman, Charlotte Chêne, Carole Nicco, Mohamed Jeljeli, Jie Qing Eu, Marie-Véronique Clément, Frédéric Batteux, Shazib Pervaiz. Therapeutic Potential of a Senolytic Approach in a Murine Model of Chronic GVHD. Biology 2023; 12(5): 647 doi: 10.3390/biology12050647
|
| 10 |
Maria Iacobescu, Cristina Pop, Alina Uifălean, Cristina Mogoşan, Diana Cenariu, Mihnea Zdrenghea, Alina Tănase, Jon Thor Bergthorsson, Victor Greiff, Mihai Cenariu, Cristina Adela Iuga, Ciprian Tomuleasa, Dan Tătaru. Unlocking protein-based biomarker potential for graft-versus-host disease following allogenic hematopoietic stem cell transplants. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1327035
|
| 11 |
Radhika Gangaraju, Yanjun Chen, Lindsey Hageman, Jessica Wu, Liton Francisco, Michelle Kung, Daniel J. Weisdorf, Stephen J. Forman, Mukta Arora, Saro H. Armenian, Smita Bhatia. Late-occurring venous thromboembolism in allogeneic blood or marrow transplant survivors: a BMTSS-HiGHS2 risk model. Blood Advances 2021; 5(20): 4102 doi: 10.1182/bloodadvances.2021004341
|
| 12 |
Christiane Faust, Tina Dietrich-Ntoukas, Philipp Steven. Zweite Umfrage zur Versorgungsstruktur der okulären Graft-versus-Host Disease in Deutschland. Klinische Monatsblätter für Augenheilkunde 2020; 237(11): 1353 doi: 10.1055/a-0854-3984
|
| 13 |
Nava R Sharma, Madalasa Pokhrel, Prakriti Lamichhane, Sumitra Paudel, Marlon E Rivera Boadla, Prabal KC, Barbara Alvarez. Every Fever Not Merely Due to Antibiotic Deficiency: Chronic Graft-Versus-Host Disease Case Report. Cureus 2024; doi: 10.7759/cureus.71367
|
| 14 |
|
| 15 |
Frida Schain, Nurgul Batyrbekova, Johan Liwing, Simona Baculea, Thomas Webb, Mats Remberger, Jonas Mattsson. Real-world study of direct medical and indirect costs and time spent in healthcare in patients with chronic graft versus host disease. The European Journal of Health Economics 2021; 22(1): 169 doi: 10.1007/s10198-020-01249-x
|
| 16 |
Teresa Lopes Ramos, Estefanía García-Guerrero, Teresa Caballero-Velázquez, Alfonso Rodríguez-Gil, Rocío Caracuel-García, Melanie Nufer, María José Robles-Frías, María Victoria Barbado, José A. Pérez-Simón. Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease. Bone Marrow Transplantation 2021; 56(12): 3049 doi: 10.1038/s41409-021-01452-1
|
| 17 |
Karin Melanie Cabanillas Stanchi, Manon Queudeville, Carmen Malaval, Judith Feucht, Patrick Schlegel, Markus Dobratz, Christian Seitz, Ingo Müller, Peter Lang, Rupert Handgretinger, Michaela Döring. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients. Journal of Cancer Research and Clinical Oncology 2019; 145(11): 2779 doi: 10.1007/s00432-019-03008-9
|
| 18 |
Irina Kostareva, Kirill Kirgizov, Elena Machneva, Nadezhda Ustyuzhanina, Nikolay Nifantiev, Yulia Skvortsova, Irina Shubina, Vera Reshetnikova, Timur Valiev, Svetlana Varfolomeeva, Mikhail Kiselevskiy. Novel and Promising Strategies for Therapy of Post-Transplant Chronic GVHD. Pharmaceuticals 2022; 15(9): 1100 doi: 10.3390/ph15091100
|
| 19 |
M. Newmarch, E. Kostantin, G. J. Tsongalis, M. Guimond, J. Roy, V. De Guire, I. Ahmad. MicroRNAs in graft-versus-host disease: a review of the latest data. Bone Marrow Transplantation 2020; 55(6): 1014 doi: 10.1038/s41409-019-0764-1
|
| 20 |
Dominique Rongvaux-Gaïda, Maëva Dupuis, Joël Poupon, Nouzha Djebrani-Oussedik, Catherine Lemonnier, François Rieger. High Response Rate and Corticosteroid Sparing with Arsenic Trioxide-Based First-Line Therapy in Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy 2022; 28(10): 679.e1 doi: 10.1016/j.jtct.2022.07.004
|
| 21 |
Zun Pwint Oo, Andrey Bychkov, Yoshiaki Zaizen, Mari Yamasue, Jun-ichi Kadota, Junya Fukuoka. Combination of pleuroparenchymal fibroelastosis with non-specific interstitial pneumonia and bronchiolitis obliterans as a complication of hematopoietic stem cell transplantation — Clues to a potential mechanism. Respiratory Medicine Case Reports 2019; 26: 244 doi: 10.1016/j.rmcr.2019.02.001
|
| 22 |
Georgine E. de Greef, Eric Braakman, Bronno van der Holt, Jeroen J.W.M. Janssen, Eefke Petersen, Vladimir Vucinic, Nicole Thuss, Meriam Grootes, Jan J. Cornelissen. The feasibility and efficacy of subcutaneous plerixafor for mobilization of peripheral blood stem cells in allogeneic HLA–identical sibling donors: results of the HOVON‐107 study. Transfusion 2019; 59(1): 316 doi: 10.1111/trf.15037
|
| 23 |
Cong Yu, Kun Li, Jianzhong Zhang. The Rose and Mackay Textbook of Autoimmune Diseases. 2024; : 1243 doi: 10.1016/B978-0-443-23947-2.00041-2
|
| 24 |
R. Stranzenbach, S. Theurich, M. Schlaak. Stellenwert der Stammzelltransplantation in der Therapie kutaner T‑Zell-Lymphome. Der Hautarzt 2017; 68(9): 716 doi: 10.1007/s00105-017-4023-3
|
| 25 |
Richard B. Presland. Application of proteomics to graft-versus-host disease: from biomarker discovery to potential clinical applications. Expert Review of Proteomics 2017; 14(11): 997 doi: 10.1080/14789450.2017.1388166
|
| 26 |
Souichi Shiratori, Kentaro Fukushima, Yasushi Onishi, Noriko Doki, Tatsunori Goto, Masaya Okada, Hirohisa Nakamae, Yoshinobu Maeda, Koji Kato, Takayuki Ishikawa, Tadakazu Kondo, Masako Toyosaki, Takashi Ikeda, Naoyuki Uchida, Akio Maki, Fumika Shimada, Takeshi Tajima, Tommaso Stefanelli, Takanori Teshima. Ruxolitinib for steroid-refractory chronic graft-versus-host disease: Japanese subgroup analysis of REACH3 study. International Journal of Hematology 2024; 120(6): 705 doi: 10.1007/s12185-024-03850-9
|
| 27 |
Samreen N. Shaikh, Emily F. Willis, Max Dierich, Yi Xu, Samuel J. S. Stuart, Glenda C. Gobe, Abate A. Bashaw, Oliver Rawashdeh, Seung Jae Kim, Jana Vukovic. CSF-1R inhibitor PLX3397 attenuates peripheral and brain chronic GVHD and improves functional outcomes in mice. Journal of Neuroinflammation 2023; 20(1) doi: 10.1186/s12974-023-02984-7
|
| 28 |
Mengmeng Zhang, Yongxia Wu, David Bastian, Supinya Iamsawat, Jinsam Chang, Anusara Daenthanasanmak, Hung D. Nguyen, Steven Schutt, Min Dai, Fangping Chen, Woong-Kyung Suh, Xue-Zhong Yu. Inducible T-Cell Co-Stimulator Impacts Chronic Graft-Versus-Host Disease by Regulating Both Pathogenic and Regulatory T Cells. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01461
|
| 29 |
Tiffany N Caza, Kenar D Jhaveri. Glomerular diseases post-hematopoietic stem cell transplantation: pathologic spectrum and plausible mechanisms. Clinical Kidney Journal 2023; 16(6): 896 doi: 10.1093/ckj/sfad023
|
| 30 |
Michelle A. Borg, Reem A. Shalabi, Richard Childs, Brian C. Wells. Alopecia Universalis and Chronic Graft-vs-Host Disease Treated With Ruxolitinib. JAMA Dermatology 2018; 154(11): 1357 doi: 10.1001/jamadermatol.2018.2927
|